Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Tuesday, December 1 2009 5:04am ET - U.S. Markets open in 4 hours and 26 minutes.
Industry Center - Biotechnology
Industry Center > Biotechnology > Anika Therapeutics, Inc. Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
Anika Therapeutics, Inc. Company Profile
Anika Therapeutics is roosterrific. The company uses hyaluronic acid, a natural polymer extracted from rooster combs and other sources, to make products that treat bone, cartilage, and soft tissue. Anika's OrthoVisc treats osteoarthritis of the knee and is available in the US and overseas. DePuy Mitek sells the product in the US. A unit of Boehringer Ingelheim sells Anika's osteoarthritis treatment for racehorses, Hyvisc. Bausch & Lomb sells two of the company's products that maintain eye shape and protect tissue during eye surgery. Other products include surgical anti-adhesives and aesthetic dermatology products.
Headlines for Anika Therapeutics, Inc.
Anika gets European approval on wrinkle product
AP - Thu Nov 19
Anika Therapeutics Receives European CE Mark Approval for "ELEVESS Light"
Business Wire - Thu Nov 19
ANIKA THERAPEUTICS INC Financials
EDGAR Online Financials - Sat Nov 7
ANIKA THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online - Tue Nov 3
More Headlines...
More on Anika Therapeutics, Inc.
Quote SEC
Chart Msgs
News Insider
Profile Financials
Reports    
Research    
Contact Information
Address: 32 Wiggins Ave.
Bedford, MA 01730
Phone:781-457-9000
Fax:781-305-9720
Financial Highlights
Fiscal Year End:December
Revenue (2008):35.80 M
Revenue Growth (1 yr):16.10%
Employees (2008):84
Employee Growth (1 yr):2.40%
Key People
President, CEO, and Director: Charles H. Sherwood
COO: Frank J. Luppino
CFO: Kevin W. Quinlan
Industry Information
Sector: Healthcare
Industry: Biotechnology
Top Competitors
Allergan, Inc. (agn)
Genzyme Biosurgery
Lifecore Biomedical, Inc.
 


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2009 Morningstar, Inc. All Rights Reserved. Company information © 2009 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2009, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo! nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo! site, a user agrees not to redistribute the information found therein.

Questions or Comments?